EnteroBiotix will be presenting at the Investival Showcase and attending the Jefferies London Healthcare Conference 2022

Past events
Written By James McIlroy
EnteroBiotix will be presenting at the Investival Showcase and attending the Jefferies London Healthcare Conference

Our CEO Dr James McIlroy will present at the LSX - partnering for Life Science executives Investival Showcase on 14th November supported by our CBO Bridget Lacey.

Together they will also attend the following Jefferies London Healthcare Conference on 15-16 November. James and Bridget will share progress on our mission to develop pioneering microbiome enhancing medicines and expand on our investment and partnering activities.

Interested in learning more? Reach out to partnering@enterobiotix.com to arrange a meeting.

James McIlroy
Previous

EnteroBiotix partners with Imperial College London to advance microbiome therapeutics
Next

EnteroBiotix receives MHRA MIA (IMP) licensure of state-of-the-art GMP manufacturing facility for producing microbiome therapeutics